Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors

Journal of Clinical Investigation

Volumn 96, Issue 1, 1995, Pages 301-308

  Salvemini, Daniela ^a   Manning, Pamela T ^a   Zweifel, Ben S ^a   Seibert, Karen ^a   Connor, Jane ^a   Currie, Mark G ^a   Needleman, Philip ^a   Masferrer, Jaime L ^a  

^a PFIZER INC   (United States)

Author keywords

carrageenan; dexamethasone; N iminoethyI L lysine; nitric oxide; prostaglandin

Indexed keywords

CARRAGEENAN; COLCHICINE; DEXAMETHASONE; LEUKOTRIENE B4; LYSINE DERIVATIVE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME INDUCTION; EXUDATE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029160559     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118035     Document Type: Article

References (31)

1. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:109-141.
2. Moncada, S., and A. Higgs. 1993. The L-Arginine-nitric oxide pathway. N. Engl J. Med. 329:2002-2012.
3. DeWitt, D. L. 1991. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim, Biophys. Acta. 1083:121-134.
4. Masferrer, J. L., and K. Seibert. 1994. Regulation of prostaglandin synthesis by glucocorticoids. Receptor. 94:25-30.
5. Seibert, K., and J. Masferrer. 1994. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor. 94:17-23.
6. Fu, J. Y., J. L. Masferrer, K. Seibert, A. Raz, and P. Needleman. 1989. The induction and suppression of prostaglandin H, synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. 265:16737-16740.
7. Masferrer, J. L., B. S. Zweifel, K. Seibert, and P. Needleman. 1990. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J. Clin. Invest. 86:1375-1379.
8. Masferrer, J. L., K. Seibert, B. S. Zweifel, and P. Needleman. 1992. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. USA. 89:3917-3921.
9. Masferrer, J. L., S. T. Reddy, B. S. Zweifel, P. Needleman, R. S. Gilbert, and H. R. Herschman. 1994. In vivo regulation of cyclooxygenase-2 but not cyclooxygenase-1 by glucocorticoids in peritoneal macrophages. J. Pharmacol. Exp. Ther. 270:1340-1344.
10. Salvemini, D., T. P. Misko, J. L. Masferrer, K. Seibert, M. G. Currie, and P. Needleman. 1993. Nitrie oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA. 90:7240-7244.
11. Hajjar, D. P., H. M. Lander, S. A. F. Pearce, and K, B. Pomerantz. 1994. Evidence for nitric oxide induction of cyclooxygenase-1 activity by hemeindependent mechanisms. FASEB (Fed. Am. Soc. Exp. Biol.) J. 10:A1432.
12. Salvemini, D., K. Seibert, J. L. Masferrer, T. P. Misko, M. G. Currie, and P. Needleman. 1994. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 93:1940-1947.
13. 2 release from the hypothalamus. Proc. Natl. Acad. Sci. USA. 89:11543-11546.
14. 2 production by vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 194:420-424.
15. Corbett, J. A., G. Kwon, J. Turk, and M. L. McDaniel. 1993. IL1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry. 32:13767-13770.
16. Sedgwick, A. D., Y. M. Sin, J. C. W. Edwards, and D. A. Willoughby. 1983. increased inflammatory reactivity in newly formed lining tissue, J. Pathol. 141:483-495.
17. Sedwick, A. D., and P. Lees. 1986. Studies of eicosanoid production in the air pouch model of synovial inflammation. Agents Actions. 18:429-438.
18. Misko, T. P., R. J. Schilling, D. Salvemini, W. M. Moore, and M. G. Currie. 1993. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214:11-16.
19. Souhami, R. L., J. W. B. Bradfield, and N. E. Parker. 1977. The effect of cytotoxic drugs on the formation of mononuclear phagocytes. In Perspectives in Inflammation. D. A. Willoughby, J. P. Giroud, and G. P. Velo. editors. MTP Press, New York. 29-39.
20. Connor, J. A., P. T. Manning, S. L. Settle, W. M. Moore, G. M. Jerome, R. K. Webber, F. S. Tjoeng, and M. G. Currie. 1995. Suppression of adjuvantinduced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 273:15-24.
21. Masferrer, J. L., B. S. Zweifel, P. T. Manning, S. D. Hauser, K. Leahy, Q. W. G. Smoth, P. C. Isakson, and K. Seibert. 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA. 91:3228-3232.
22. Radomski, M. W., R. M. J. Palmer, and S. Moncada. 1990. Glucocorticoids inhibit the expression of an inducible but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA. 87:10043- 10047.
23. Knowles, R. G., M. Salter, S. L. Brooks, and S. Moncada. 1990. Antiinflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun. 172:1042-1048.
24. Rees, D. D., S. Cellek, R. M. J. Palmer, and S. Moncada. 1990. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem. Biophys. Res. Commun. 173:541-547.
25. 6-(1-lminoethyl) lysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. 37:3886-3888.
26. Futaki, N., K. Yoshikawa, Y. Hamasaka, I. Arai, S. Higuchi, H. Iizuka, and S. Otomo. 1993. NS-398, a novel non-steroidal antiinflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24:105-110.
27. Futaki, N., I. Arai, Y. Hamasaka, S. Takahashi, S. Higuchi, and S. Otomo. 1993. Selective inhibition of NS398 on prostanoid production in inflamed tissue in carrageenan-air-pouch inflammation. J. Pharm. Pharmacol. 45:753-755.
28. Salvemini, D., S. L. Settle, J. L. Masferrer, K. Seibert, M. G. Currie, and P. Needleman. 1995. Regulation of prostaglandin production by nitric oxide: an in vivo analysis. Br. J. Pharmacol. 114:1171-1178.
29. G-nitro arginine (L-NOARG), a novel, L-arginine reversible inhibitor of endothelium dependent vasodilation in vitro, Br. J. Pharmacol. 99:408-412.
30. Vane, J. R., J. A. Mitchell, I. Appleton. A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D. A. Willoughby. 1994. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl, Acad. Sci. USA 91:2046-2050.
31. Flynn, B. L. 1994. Rheumatoid arthritis and osteoarthritis: current and future therapies. Am. Pharm. 34:31-42.